Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Albert David Ltd

NSE: ALBERTDAVD · BSE: 524075 · Pharmaceuticals & Biotechnology · 19 announcements

Share price
₹812.75
Market cap
₹463.9 Cr
Revenue (annual)
₹333.6 Cr
Net profit (annual)
₹-1.49 Cr
P/E (TTM)
20.6×Sector 47.3×
Promoter holding
62.24%+0.00% QoQ
FII holding
0.57%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:38 IST BSE
Management Change

Albert David Management Change

Dr. Kuntal Ganguly has resigned as Head of R&D at Albert David Limited, effective August 5, 2026.

14:59 IST BSE
Management Change

Albert David Management Change

Albert David Ltd announced the resignation of Cluster Head Mr. Saikath Banerjee, effective July 4, 2026. His departure marks a change in senior management for the company.

15:09 IST BSE
Management Change

Albert David Management Change

Albert David Limited announced the resignation of Mr. Chandra Bhushan Thakur as Head-Operations (Ghaziabad). The departure was effective from May 29, 2026, due to personal reasons.

17:56 IST NSE
Management Change

Albert David Management Change

Albert David Limited appointed Amit Mahla as Chief Executive Officer effective May 12, 2026. He brings 28 years of pharmaceutical leadership experience from JB Pharma and Cipla.